Literature DB >> 15918827

Survey of arrangements for anaesthesia for interventional neuroradiology for aneurysmal subarachnoid haemorrhage.

S T Webb1, P A Farling.   

Abstract

The management of patients with subarachnoid haemorrhage following rupture of an intracranial aneurysm is changing. The recent introduction of endovascular occlusion of the aneurysm using detachable coils offers an alternative to craniotomy and clipping of the aneurysm for the prevention of recurrent aneurysmal haemorrhage. The aim of this survey was to evaluate the current provision of peri-operative care for patients with an aneurysmal subarachnoid haemorrhage in the United Kingdom and Republic of Ireland. A survey was conducted of the 34 neuroscience centres which provide an adult neurosurgery service in the United Kingdom and Republic of Ireland. Most centres reported an increasing role for coiling, and a decreasing role for clipping in the management of aneurysmal subarachnoid haemorrhage. The provision of peri-operative care for patients undergoing interventional neuroradiology procedures varied greatly between centres. Neurovascular services in the UK are being reorganised and adequate staff and facilities should be available for the peri-operative care of patients undergoing interventional neuroradiology procedures.

Entities:  

Mesh:

Year:  2005        PMID: 15918827     DOI: 10.1111/j.1365-2044.2005.04191.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  The efficacy of pre-warming on reducing intraprocedural hypothermia in endovascular coiling of cerebral aneurysms.

Authors:  Keun Man Shin; Jung Hwan Ahn; Il Seok Kim; Jong Young Lee; Sang Soo Kang; Sung Jun Hong; Hyun Mo Chung; Hee Jae Lee
Journal:  BMC Anesthesiol       Date:  2015-01-21       Impact factor: 2.217

2.  A Questionnaire Survey of Management of Patients with Aneurysmal Subarachnoid Haemorrhage in Poland.

Authors:  Mariusz Hofman; Norbert Hajder; Izabela Duda; Łukasz J Krzych
Journal:  Int J Environ Res Public Health       Date:  2020-06-11       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.